tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DYN Stock Latest News

Dyne Therapeutics price target raised to $21 from $12 at Bernstein
The FlyDyne Therapeutics price target raised to $21 from $12 at Bernstein
1d ago
DYN
Dyne Therapeutics price target lowered to $17 from $18 at JPMorgan
PremiumThe Fly
Dyne Therapeutics price target lowered to $17 from $18 at JPMorgan
12d ago
DYN
Dyne Therapeutics price target lowered to $11 from $13 at Oppenheimer
PremiumThe Fly
Dyne Therapeutics price target lowered to $11 from $13 at Oppenheimer
14d ago
DYN
NVS
Dyne Therapeutics price target lowered to $38 from $41 at Evercore ISI
PremiumThe Fly
Dyne Therapeutics price target lowered to $38 from $41 at Evercore ISI
20d ago
DYN
Dyne Therapeutics price target raised to $46 from $38 at H.C. Wainwright
PremiumThe Fly
Dyne Therapeutics price target raised to $46 from $38 at H.C. Wainwright
20d ago
DYN
Positive Outlook for Dyne Therapeutics: Strong Financial Performance and Promising Clinical Developments Support Buy Rating
PremiumRatingsPositive Outlook for Dyne Therapeutics: Strong Financial Performance and Promising Clinical Developments Support Buy Rating
20d ago
DYN
Dyne Therapeutics Advances in Neuromuscular Disease Therapies
Premium
Company Announcements
Dyne Therapeutics Advances in Neuromuscular Disease Therapies
20d ago
DYN
Dyne Therapeutics reports Q3 EPS (76c), consensus (85c)
Premium
The Fly
Dyne Therapeutics reports Q3 EPS (76c), consensus (85c)
21d ago
DYN
Dyne Therapeutics announces Z-rostudirsen remains on track for 1Q27 launch
PremiumThe Fly
Dyne Therapeutics announces Z-rostudirsen remains on track for 1Q27 launch
21d ago
DYN
Dyne Therapeutics Advances DYNE-101 Study for Myotonic Dystrophy Type 1
PremiumCompany Announcements
Dyne Therapeutics Advances DYNE-101 Study for Myotonic Dystrophy Type 1
30d ago
DYN
Dyne Therapeutics: Positioned for Growth in the RNA Therapeutics Market Amid Industry Validation
PremiumRatings
Dyne Therapeutics: Positioned for Growth in the RNA Therapeutics Market Amid Industry Validation
30d ago
DYN
Dyne Therapeutics rises 41.7%
PremiumThe Fly
Dyne Therapeutics rises 41.7%
30d ago
DYN
Dyne Therapeutics rises 42.4%
PremiumThe FlyDyne Therapeutics rises 42.4%
30d ago
DYN
Video: Merger Monday with deals announced in biotechnology and banking
Premium
The Fly
Video: Merger Monday with deals announced in biotechnology and banking
1M ago
AWK
DYN
Avidity acquisition has positive read for Dyne Therapeutics, says Morgan Stanley
Premium
The Fly
Avidity acquisition has positive read for Dyne Therapeutics, says Morgan Stanley
1M ago
DYN
NVS
Dyne Therapeutics up 37% after Avidity gets bought
PremiumThe Fly
Dyne Therapeutics up 37% after Avidity gets bought
1M ago
DYN
NVS
Dyne Therapeutics Positioned for Growth with FORCE Platform and Key Upcoming Catalysts
PremiumRatings
Dyne Therapeutics Positioned for Growth with FORCE Platform and Key Upcoming Catalysts
1M ago
DYN
Dyne Therapeutics: Promising Advancements in Neuromuscular Treatments Drive Buy Rating
PremiumRatings
Dyne Therapeutics: Promising Advancements in Neuromuscular Treatments Drive Buy Rating
1M ago
DYN
Dyne Therapeutics downgraded to Perform at Oppenheimer following additional data
PremiumThe Fly
Dyne Therapeutics downgraded to Perform at Oppenheimer following additional data
2M ago
DYN
Dyne Therapeutics downgraded to Perform from Outperform at Oppenheimer
PremiumThe FlyDyne Therapeutics downgraded to Perform from Outperform at Oppenheimer
2M ago
DYN
Dyne announces additional one-year data from ACHIEVE study
Premium
The Fly
Dyne announces additional one-year data from ACHIEVE study
2M ago
DYN
Dyne Therapeutics Elects Brian Posner to Board
Premium
Company Announcements
Dyne Therapeutics Elects Brian Posner to Board
2M ago
8K
DYN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >